The major U.S. stock market indices finally corrected after a 9-month sideways trend. The ‘big’ news this week for stocks was undoubtedly that the four indices all closed below their 200-day moving average, which IS an important breakdown.The key observation on the chart below, is the violation of the steep uptrend (highlighted with the rising green dotted line), which started […]
Below is just a snapshot of the Full Report
(login required) Not a member yet? Join Now.
This report is provided free each week by McAlinden Research Partners to members of Hedge Connection.
Big Pharma Refills its Blockbuster Pipeline While the Generics Consolidate
MCALINDEN RESEARCH PARTNERS | DIBS
This Week’s Issue Cluster: Pharma
Generic drugmakers get on the megamerger bandwagon
New blockbuster branded drugs are coming down the pike, including Alzheimer’s, malaria, and cholesterol.
One of the most popular and well-known names in the biotech world is definitely Biogen (BIIB-Analyst Report). This large cap stock has been a staple of investor portfolios in the biotechnology space for some time, while it is also one of the behemoths of the sector, closing in on $100 billion in market cap.BIIB might be due for a breather […]
The Celgene Corporation (CELG – Analyst Report) – Juno Therapeutics’ (JUNO – Analyst Report) immunotherapy deal worth at least a billion dollars was the main story in the biotech sector this week. While concerns are being raised about the high price tag, the deal just goes to show the growing interest in the field of immunotherapy. Meanwhile, quite a few […]
Benchmarks gained around 1% on Thursday after the Federal Reserve hinted that it will move slowly on raising interest rates. A majority of Fed officials had said on Wednesday that the economy is ready for a rate hike this year. Only 2 out of the 17 officials believe the central bank should not raise rates before next year. Meanwhile, consumer […]
Capitalize on Comeback Stories in Micro-Cap Biotech StocksCompanies / BioTechJun 17, 2015 – 09:55 PM GMTBy: TLSReportThe list of problems with investing in micro-cap biotech stocks begins with extreme volatility and lack of liquidity and ends with the inability to get validation from sophisticated investors who are unable to own such small companies. Nevertheless, sift through the pile and investors […]
Benchmarks ended the first trading day of the week in the red, dragged down by declines in technology stocks. Drop in airline stocks also weighed on the broader markets. The lack of progress related to Greece’s debt deal with its creditors also dented investor sentiment. Meanwhile, Friday’s upbeat jobs data continued to intensify concerns about rate hike as early as […]
Jun. 4, 2015, 5:35 PM
Screengrab via YouTubeAnother Wall Street analyst is making comparisons to the Titanic.This time it’s editor and publisher of the Gloom, Boom & Doom Report, Marc Faber.Faber warned that investors should stop bickering over which assets are the best, and start preparing their own escape plan. That is, if they don’t want the same fate as […]
Benchmarks ended slightly lower after a slump in utility stocks offset rise in energy shares. While high-dividend utility stocks took a beating due to rise in bond yields, energy shares gained as weaker dollar pushed oil prices higher. The euro strengthened against the dollar on upbeat Eurozone inflation data. Moreover, encouraging news on Greece’s debt crisis boosted the single currency.For […]
Benchmarks ended the first trading day of June with modest gains following mixed economic reports. While reports on construction spending and manufacturing were encouraging, data on consumer spending was disappointing. Investors are keeping an eye on economic data for clues on when the Federal Reserve will hike interest rates.For a look at the issues currently facing the markets, make sure […]